FDA 483 - Emergent Biodefense Operations Lansing LLC
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Bioport Corporation, a vaccine manufacturer in Lansing, Michigan, revealed significant quality system deficiencies. The firm failed to conduct complete investigations into manufacturing failures and deviations, maintain equipment properly, and ensure the timely implementation and tracking of corrective actions. Additionally, issues were noted with computer system qualification, visual inspection criteria, and the completeness and timeliness of Annual Product Reviews.
- Product Type
- Biologics
ID · 90f884c5-df6f-416f-9716-60c95553ca37